Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well vorinostat works in treating patients with
progressive metastatic prostate cancer. Drugs used in chemotherapy, such as vorinostat, work
in different ways to stop the growth of tumor cells, either by killing the cells or by
stopping them from dividing. Vorinostat may also stop the growth of tumor cells by blocking
some of the enzymes needed for cell growth.